pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Hospitals Prepare Lobbying Effort to Counter $1 Trillion Health Care Funding Cuts

Aug 27, 2026·read at STAT ↗RegulatoryNegative

Hospitals are gearing up to lobby Congress after a projected $1 trillion reduction in health‑care spending, which was part of recent tax‑cut legislation.

Hospital leaders say they will seek higher government payments, new reimbursement incentives, and streamlined regulations to offset the cuts.

According to the STAT D.C. Diagnosis newsletter, much of the hospitals’ political capital is now being spent on delaying and mitigating the funding reductions rather than on other initiatives.

The article notes that the lobbying push reflects broader uncertainty in the health‑care system as policymakers balance tax policy with hospital financing.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Hospitals plot their response to funding cuts”

read at STAT ↗
453 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Oncology4Cardiology2Vaccine

related stories

  • 2d agoCellares cuts jobs after losing pharma customerBioSpace
  • Aug 20Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a studySTAT
  • Aug 14Capricor shares spike on CEO comments; Cytokinetics sues Bristol MyersBioPharma Dive
  • Aug 7Is the biotech capital of the world moving?STAT
  • Aug 6STAT+: FDA approves Replimune melanoma drug previously rejected twiceSTAT